These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 5801631)
41. [Study of a non-barbiturate hypnotic "FH 040-3" (mepronizine) in a psychiatric setting]. Subra G; Noyer J; Legros P Encephale; 1967; 56(5):469-79. PubMed ID: 4873379 [No Abstract] [Full Text] [Related]
42. [Clinical experiences with the myotonolytic chlormezanone]. Krüger E; Rabending G; Koch RD Psychiatr Neurol Med Psychol (Leipz); 1966 Apr; 18(4):155-8. PubMed ID: 4861472 [No Abstract] [Full Text] [Related]
43. [Trial of treatment with oxazepam in anxiety and depressive states in the course of neuroses and psychoses]. Jezierska A; Klosińska B; Wierzbicki T Psychiatr Pol; 1968; 2(1):33-5. PubMed ID: 5669193 [No Abstract] [Full Text] [Related]
44. [Controlled clinical trial of dihydroergocristine in neuropsychiatric disorders in cerebrovascular insufficiency]. Muchnik S Boll Chim Farm; 1982 May; 121(5):33S-46S. PubMed ID: 6814466 [No Abstract] [Full Text] [Related]
45. [Oxazepam: tranquilizing agent in current medical practice]. Ehrhart C; Ciistau P Lyon Med; 1969 Oct; 222(37):633-6. PubMed ID: 5403551 [No Abstract] [Full Text] [Related]
46. [Iatrogenic damage possibilities in the drug therapy of neurologic and psychiatric diseases]. Gehlen W Med Klin; 1977 Aug; 72(32-33):1288-300. PubMed ID: 331056 [No Abstract] [Full Text] [Related]
49. The episodic nature of anxiety and its treatment with oxazepam. Imlah NW Acta Psychiatr Scand Suppl; 1978; (274):94-8. PubMed ID: 282779 [TBL] [Abstract][Full Text] [Related]
50. Oxazepam: An overview. Ayd FJ Dis Nerv Syst; 1975 May; 36(5 Pt. 2):14-6. PubMed ID: 1140060 [No Abstract] [Full Text] [Related]
51. [Analysis of the anxiety-suppressing and autonomic hyperreactivity-suppressing effects of Oxazepam in psychoneuroses]. Cernibori A Minerva Med; 1971 Mar; 62(26):1393-9. PubMed ID: 5554156 [No Abstract] [Full Text] [Related]
52. [On the passage into the cerebrospinal fluid of a new tetracycline derivative: N1, N1-diethyleniminobiguanido-methyl-tetracycline. Research in subjects with intact meninges]. Tarantola A; Pellegrini R; Ruozi P Clin Ter; 1968 Sep; 46(5):447-55. PubMed ID: 5747195 [No Abstract] [Full Text] [Related]
53. Homicidal somnambulism: a case report. Broughton R; Billings R; Cartwright R; Doucette D; Edmeads J; Edwardh M; Ervin F; Orchard B; Hill R; Turrell G Sleep; 1994 Apr; 17(3):253-64. PubMed ID: 7939126 [TBL] [Abstract][Full Text] [Related]
55. [The use of Adumbran 50 in psychiatry]. von Hanxleden V Ther Ggw; 1976 Jan; 115(1):97-108. PubMed ID: 1257921 [No Abstract] [Full Text] [Related]
56. [Features of the pharmacotherapy of nervous and mental diseases in gerontology]. Man'kovskiĭ NB; Burchinskiĭ SG; Tordiia GD Klin Med (Mosk); 1986 Sep; 64(9):12-7. PubMed ID: 3784491 [No Abstract] [Full Text] [Related]
57. [Use of a pediatric form of oxazepam in child psychiatry]. Knobel M; Zanzottera M; Porley G Prensa Med Argent; 1971 Oct; 58(32):1622-5. PubMed ID: 4943250 [No Abstract] [Full Text] [Related]